Glucagon-like peptide-1 receptor agonists linked to better recovery within 90 days after hip and knee replacement surgery

A. Judge reports grants or contracts from NIHR, HDR UK, Versus Arthritis, Healthcare Quality Improvement Partnership (HQIP), Royal College of Physicians (RCP), Tommy’s, and the Health Foundation, participates on a range of Data Safety Monitoring or Advisory Boards, and was co-chair Versus Arthritis Research Expert group from September 2022 to October 2025, all of which are unrelated to this study. A. Price reports consulting fees from Zimmer Biomet and Medacta, unrelated to this study. A. Alvand reports royalties or licenses from Adler Orthopaedics, consulting fees from Medacta International, Adler Orthopedics, BD, Solventum, Smith & Nephew, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Ethicon, Zimmer Biomet, Medacta, Adler Ortho, Solventum, Molnlycke, Biocomposites, participation on a Data Safety Monitoring Board or Advisory Board for BD and Smith & Nephew, and stock or stock options with PSI, all of which are unrelated to this study.